Rabusertib

Scientific Overview: Selective CHK1 inhibitor; combined with gemcitabine for solid tumors. Gemcitabine sensitisation via CHK1

Mechanism of Action: CHK1 Inhibitor (selective)

Purity: ≥99%  |  Molecular Formula: N/A

For Research Use Only. Not intended for diagnostic, therapeutic, or clinical applications.